RECRUITING

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

Official Title

ASk Questions in GYnecologic Oncology (ASQ-GYO): A Randomized Controlled Trial of a Question Prompt List Communication Intervention in Outpatient Gynecologic Oncology Clinics

Quick Facts

Study Start:2024-04-04
Study Completion:2027-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06339827

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age
  2. * Understands spoken and written English
  3. * Able to consent to study participation
  4. * Biopsy confirmed gynecologic cancer diagnosis (ovarian, endometrial, cervical, vulvar, or vaginal cancer or Gestational Trophoblastic Disease) OR have imaging and/or laboratory findings highly concerning for a cancer diagnosis and have not seen a Gynecologic Oncologist
  1. * pathologic diagnosis of dysplasia only (cervical, vulvar, or endometrial)
  2. * History and/or imaging/laboratory findings more indicative of a non-cancer diagnosis
  3. * Previous treatment discussion with a Gynecologic Oncologist

Contacts and Locations

Study Contact

Ira Winer, MD PhD
CONTACT
3135769194
iwiner@med.wayne.edu
Elizabeth Johns, MD MS
CONTACT
313-576-8441
hr3132@wayne.edu

Principal Investigator

Ira Winer, MD PhD
PRINCIPAL_INVESTIGATOR
Barbara Ann Karmanos Cancer Institute

Study Locations (Sites)

Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201
United States

Collaborators and Investigators

Sponsor: Ira Winer

  • Ira Winer, MD PhD, PRINCIPAL_INVESTIGATOR, Barbara Ann Karmanos Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-04
Study Completion Date2027-05

Study Record Updates

Study Start Date2024-04-04
Study Completion Date2027-05

Terms related to this study

Additional Relevant MeSH Terms

  • Ovarian Cancer
  • Endometrial Cancer
  • Cervical Cancer
  • Vulvar Cancer
  • Vaginal Cancer
  • Gestational Trophoblastic Disease